A Pečauer’s Reviews > Bottle of Lies: The Inside Story of the Generic Drug Boom > Status Update
A Pečauer
is 49% done
Baker's adherence to lawful regulatory requirements affected the sweet bottom line. "Consequently, some in [the FDA] began to target a different problem--Peter Baker himself."
They have hated those who are presenting their cases in court, detesting the one who speaks truthfully. (Amos 5:10) (lol)
— Sep 01, 2025 03:33PM
They have hated those who are presenting their cases in court, detesting the one who speaks truthfully. (Amos 5:10) (lol)
Like flag
A’s Previous Updates
A Pečauer
is 49% done
Chapter 16: I’m glad that the only pharmaceutical companies in my investment portfolio are Japanese. I feel assured that any possible fraud committed on their part is largely limited to the financial sort, and is bound to be much less sloppy.
— Aug 31, 2025 10:57PM
A Pečauer
is 28% done
"It is not in Indian culture to record our data while we conduct experiments."
A quote from Rambaxy Laboratories' Head of Analytical Research.
One of the funnier quotes I’ve read this year.
— Aug 31, 2025 08:25PM
A quote from Rambaxy Laboratories' Head of Analytical Research.
One of the funnier quotes I’ve read this year.
A Pečauer
is 23% done
Chapter 7: The reluctance of pharmaceutical companies to prematurely yield their legitimate patent licenses "even brought accusations of genocide."
Note that it costs zero dollars to make an a vague accusation of genocide, regardless of its adherence to the definition. That low financial barrier predictably means everything we don't like is genocide.
It's not an especially notable observation.
— Aug 31, 2025 07:46PM
Note that it costs zero dollars to make an a vague accusation of genocide, regardless of its adherence to the definition. That low financial barrier predictably means everything we don't like is genocide.
It's not an especially notable observation.
